共 2 条
SAFETY AND EFFICACY OF REPEATED SEQUENTIAL ADMINISTRATIONS OF RE-186(SN)HEDP AS PALLIATIVE THERAPY FOR PAINFUL SKELETAL METASTASES - INITIAL CASE-REPORTS OF 2 PATIENTS
被引:19
作者:
ENGLARO, EE
SCHRODER, LE
THOMAS, SR
WILLIAMS, CC
MAXON, HR
机构:
[1] UNIV CINCINNATI,MED CTR,EUGENE L SAENGER RADIOISOTOPE LAB,MAIL LOCAT 577,234 GOODMAN ST,CINCINNATI,OH 45267
[2] UNIV CINCINNATI,MED CTR,DEPT RADIOL,DIV MED PHYS,CINCINNATI,OH 45267
[3] UNIV CINCINNATI,MED CTR,DEPT INTERNAL MED,DIV HEMATOL ONCOL,CINCINNATI,OH 45267
关键词:
D O I:
10.1097/00003072-199201000-00012
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Single intravenous injections of 30 to 35 mCi (1,110 to 1,295 MBq) of Re-186(Sn)HEDP previously have been shown to result in palliation of painful skeletal metastases from prostate cancer. There are no reports of patients receiving repetitive Re-186(Sn)HEDP therapy. We have followed two such patients who received multiple (five to seven) injections of Re-186(Sn)HEDP at 2-month intervals. Each experienced a sustained decrease in both pain and analgesic intake. The only evident clinical or biochemical toxicity was a mild progressive decline in their total platelet counts.
引用
收藏
页码:41 / 44
页数:4
相关论文